These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 12677010)

  • 1. Deletion of the P2X7 nucleotide receptor reveals its regulatory roles in bone formation and resorption.
    Ke HZ; Qi H; Weidema AF; Zhang Q; Panupinthu N; Crawford DT; Grasser WA; Paralkar VM; Li M; Audoly LP; Gabel CA; Jee WS; Dixon SJ; Sims SM; Thompson DD
    Mol Endocrinol; 2003 Jul; 17(7):1356-67. PubMed ID: 12677010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of the pore-forming P2X7 receptor inhibits formation of multinucleated human osteoclasts in vitro.
    Gartland A; Buckley KA; Bowler WB; Gallagher JA
    Calcif Tissue Int; 2003 Oct; 73(4):361-9. PubMed ID: 12874700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo characterization of skeletal phenotype of genetically modified mice.
    Ke HZ
    J Bone Miner Metab; 2005; 23 Suppl():84-9. PubMed ID: 15984421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of the insulin-like growth factor-1 gene in osteocytes impairs developmental bone growth in mice.
    Sheng MH; Zhou XD; Bonewald LF; Baylink DJ; Lau KH
    Bone; 2013 Jan; 52(1):133-44. PubMed ID: 23032105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The P2Y13 receptor regulates phosphate metabolism and FGF-23 secretion with effects on skeletal development.
    Wang N; Robaye B; Gossiel F; Boeynaems JM; Gartland A
    FASEB J; 2014 May; 28(5):2249-59. PubMed ID: 24487286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
    Okamoto M; Murai J; Yoshikawa H; Tsumaki N
    J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disordered osteoclast formation and function in a CD38 (ADP-ribosyl cyclase)-deficient mouse establishes an essential role for CD38 in bone resorption.
    Sun L; Iqbal J; Dolgilevich S; Yuen T; Wu XB; Moonga BS; Adebanjo OA; Bevis PJ; Lund F; Huang CL; Blair HC; Abe E; Zaidi M
    FASEB J; 2003 Mar; 17(3):369-75. PubMed ID: 12631576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-1 plays an important role in the bone metabolism under physiological conditions.
    Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
    Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice.
    Li M; Healy DR; Li Y; Simmons HA; Crawford DT; Ke HZ; Pan LC; Brown TA; Thompson DD
    Bone; 2005 Jul; 37(1):46-54. PubMed ID: 15869929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteinase-activated receptor-2 is required for normal osteoblast and osteoclast differentiation during skeletal growth and repair.
    Georgy SR; Pagel CN; Ghasem-Zadeh A; Zebaze RM; Pike RN; Sims NA; Mackie EJ
    Bone; 2012 Mar; 50(3):704-12. PubMed ID: 22173052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption.
    Xing L; Carlson L; Story B; Tai Z; Keng P; Siebenlist U; Boyce BF
    J Bone Miner Res; 2003 Feb; 18(2):260-9. PubMed ID: 12568403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe developmental bone phenotype in ClC-7 deficient mice.
    Neutzsky-Wulff AV; Sims NA; Supanchart C; Kornak U; Felsenberg D; Poulton IJ; Martin TJ; Karsdal MA; Henriksen K
    Dev Biol; 2010 Aug; 344(2):1001-10. PubMed ID: 20599900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of osteoclast-rich and osteoclast-poor osteopetrosis in adult mice sheds light on the role of the osteoclast in coupling bone resorption and bone formation.
    Thudium CS; Moscatelli I; Flores C; Thomsen JS; Brüel A; Gudmann NS; Hauge EM; Karsdal MA; Richter J; Henriksen K
    Calcif Tissue Int; 2014 Jul; 95(1):83-93. PubMed ID: 24838599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
    Udagawa N; Takahashi N; Yasuda H; Mizuno A; Itoh K; Ueno Y; Shinki T; Gillespie MT; Martin TJ; Higashio K; Suda T
    Endocrinology; 2000 Sep; 141(9):3478-84. PubMed ID: 10965921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycoprotein130 (Gp130)/interleukin-6 (IL-6) signalling in osteoclasts promotes bone formation in periosteal and trabecular bone.
    Johnson RW; McGregor NE; Brennan HJ; Crimeen-Irwin B; Poulton IJ; Martin TJ; Sims NA
    Bone; 2015 Dec; 81():343-351. PubMed ID: 26255596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multinucleated osteoclast formation in vivo and in vitro by P2X7 receptor-deficient mice.
    Gartland A; Buckley KA; Hipskind RA; Perry MJ; Tobias JH; Buell G; Chessell I; Bowler WB; Gallagher JA
    Crit Rev Eukaryot Gene Expr; 2003; 13(2-4):243-53. PubMed ID: 14696971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P2X7 nucleotide receptors mediate blebbing in osteoblasts through a pathway involving lysophosphatidic acid.
    Panupinthu N; Zhao L; Possmayer F; Ke HZ; Sims SM; Dixon SJ
    J Biol Chem; 2007 Feb; 282(5):3403-12. PubMed ID: 17135244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
    Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
    Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double disruption of α2A- and α2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype.
    Fonseca TL; Jorgetti V; Costa CC; Capelo LP; Covarrubias AE; Moulatlet AC; Teixeira MB; Hesse E; Morethson P; Beber EH; Freitas FR; Wang CC; Nonaka KO; Oliveira R; Casarini DE; Zorn TM; Brum PC; Gouveia CH
    J Bone Miner Res; 2011 Mar; 26(3):591-603. PubMed ID: 20814988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The P2X7 nucleotide receptor mediates skeletal mechanotransduction.
    Li J; Liu D; Ke HZ; Duncan RL; Turner CH
    J Biol Chem; 2005 Dec; 280(52):42952-9. PubMed ID: 16269410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.